M. Piccart
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Oncology top 5%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
Papers in
-
- Advanced Breast Cancer Therapies 12
- Lung Cancer Treatments and Mutations 5
- Oncology 19
- Cancer Treatment and Pharmacology 9
- HER2/EGFR in Cancer Research 5
- Co-authors
- Fátima Cardoso (6 shared papers)P.F. Bruning (3 shared papers)Tanja Čufer (2 shared papers)G. Atalay (2 shared papers)L. Mauriac (3 shared papers)Laura Biganzoli (4 shared papers)Ahmad Awada (3 shared papers)Robert E. Coleman (2 shared papers)
- Journals
- Cancer Research (11 papers)Annals of Oncology (10 papers)European Journal of Cancer (8 papers)Journal of Clinical Oncology (7 papers)European Journal of Cancer Supplements (1 paper)
- Partner nations
- BelgiumFranceUnited States
In The Last Decade
M. Piccart
35 papers receiving 865 citations
Peers
Comparison fields: 5 of 62
- Cancer Research 325
- Oncology 487
- Dermatology 45
- Pulmonary and Respiratory Medicine 122
- Pharmacology 46
Countries citing papers authored by M. Piccart
This map shows the geographic impact of M. Piccart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Piccart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Piccart more than expected).
Fields of papers citing papers by M. Piccart
This network shows the impact of papers produced by M. Piccart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Piccart. The network helps show where M. Piccart may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Piccart, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 167 | |
| 2 | 2003 | 153 | |
| 3 | 2003 | 87 | |
| 4 | 1993 | 86 | |
| 5 | 2006 | 68 | |
| 6 | 2003 | 59 | |
| 7 | 2007 | 49 | |
| 8 | 2009 | 42 | |
| 9 | 2016 | 27 | |
| 10 | 2012 | 15 | |
| 11 | AT (doxorubicin-Taxol) versus AC (doxorubicin-cyclophosphamide) as first line chemotherapy in metastatic breast cancer (MBC): A phase III study. (originally presented at ASCO 2000. Abstract 282) | 2000 | 13 |
| 12 | 2011 | 12 | |
| 13 | 2005 | 12 | |
| 14 | 2014 | 10 | |
| 15 | 2009 | 9 | |
| 16 | Phase II, open label study of SB-715992 (Ispinesib) in subjects with advanced or metastatic breast cancer | 2005 | 9 |
| 17 | Combined treatment with the LHRH-agonist buserelin (LHRH-A) and tamoxifen (TAM) vs single treatment with each drug alone in premenopausal metastatic breast cancer. Final results of EORTC study 10881 | 1998 | 8 |
| 18 | 2020 | 8 | |
| 19 | 2013 | 8 | |
| 20 | 2012 | 8 |
About M. Piccart
M. Piccart is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Genetics and Molecular Biology, having authored 38 papers that have together received 892 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (12 papers), Breast Cancer Treatment Studies (12 papers), Cancer Treatment and Pharmacology (9 papers), Estrogen and related hormone effects (7 papers), Cancer Genomics and Diagnostics (6 papers), HER2/EGFR in Cancer Research (5 papers), Lung Cancer Treatments and Mutations (5 papers) and BRCA gene mutations in cancer (2 papers). The work is most often cited by research in Cancer Research (325 citations), Oncology (487 citations), Dermatology (45 citations), Pulmonary and Respiratory Medicine (122 citations) and Pharmacology (46 citations). M. Piccart has collaborated with scholars based in Belgium, France and United States. Frequent co-authors include Fátima Cardoso, P.F. Bruning, Tanja Čufer, G. Atalay, L. Mauriac, Laura Biganzoli, Ahmad Awada, Robert E. Coleman, Hervé Bonnefoi and Anne Hamilton. Their work appears in journals such as Cancer Research, Annals of Oncology, European Journal of Cancer, Journal of Clinical Oncology and European Journal of Cancer Supplements.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.